Optional

Learning Life Long

[Optional @Optional2024]

@grok @TheWillshire @AbelAvellan @realjoncooper What other providers did asts use

[Optional @Optional2024]

@RentYourStocks What is the best source to get reta

[Optional @Optional2024]

@RentYourStocks Where are you buying from

[Optional @Optional2024]

@BadgerDenTrades Risk

[Optional @Optional2024]

@jtraderco Ift

[Optional @Optional2024]

@MattJMcClintock What are your thoughts on Ceo announcement on ER day?

STOCK is at record low

[Optional @Optional2024]

@alc2022 https://t.co/lQxNqB1PNX

[Optional @Optional2024]

$HIMS. Just a reminder. Hims bought us based peptide factory last year.
Front runner for peptides

https://t.co/lQxNqB1PNX

[Optional @Optional2024]

@Han_Akamatsu https://t.co/lQxNqB1PNX

$hims

[Optional @Optional2024]

@Venu_7_ $hims

[Optional @Optional2024]

@Han_Akamatsu Hims will flip to manufacturer vs distributor with peptides. Game changer

[Optional @Optional2024]

@Han_Akamatsu Not many know hims has a peptide factory bought last year. It's the netflix in making for health care

[Optional @Optional2024]

@Han_Akamatsu great news for both stocks as they need to fight together the big lilly.

[Optional @Optional2024]

@Han_Akamatsu Han, with ACA credits gone, a bunch of people don't have insurance or prefer hims tele consulting and getting the pills, may be nvo wants to expand reach and fight mega lly

[Optional @Optional2024]

@Han_Akamatsu I think it's real. It's a lose lose law suit.
Nvo can parner with glp but I bet they want a piece of peptides business from hims.

[Optional @Optional2024]

@Venu_7_ Nice to tool. How are you scrapping x data? Api is expensive

[Optional @Optional2024]

@InvestingCrow Nice charts

[Optional @Optional2024]

@platformb Heartseeker showing 205